Dronabinol Versus Placebo in Treatment and Prevention of Highly Active Anti-Retroviral Therapy (HAART)-Related Nausea and Vomiting
Public ClinicalTrials.gov record NCT00642499. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Double-Blind, Randomized, Parallel-Group, Pilot Study of Oral Dronabinol Versus Placebo in the Treatment or Prevention of Highly Active Antiretroviral Therapy (HAART)-Related Nausea and Vomiting
Study identification
- NCT ID
- NCT00642499
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Solvay Pharmaceuticals
- Industry
- Enrollment
- 103 participants
Conditions and interventions
Interventions
- Dronabinol Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 70 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 31, 2003
- Primary completion
- Mar 31, 2005
- Completion
- Mar 31, 2005
- Last update posted
- Apr 1, 2008
2003 – 2005
United States locations
- U.S. sites
- 36
- U.S. states
- 15
- U.S. cities
- 30
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Site 911 | Bakersfield | California | — | — |
| Site 919 | Fresno | California | — | — |
| Site 924 | Los Angeles | California | — | — |
| Site 932 | Los Angeles | California | — | — |
| Site 926 | Palm Springs | California | — | — |
| Site 946 | Pasadena | California | — | — |
| Site 913 | Tarzana | California | — | — |
| Site 907 | Altamonte Springs | Florida | — | — |
| Site 948 | Miami | Florida | — | — |
| Site 951 | Miami | Florida | — | — |
| Site 953 | Miami | Florida | — | — |
| Site 959 | Miami | Florida | — | — |
| Site 954 | North Palm Beach | Florida | — | — |
| Site 957 | Pensacola | Florida | — | — |
| Site 923 | Port Saint Lucie | Florida | — | — |
| Site 929 | Sarasota | Florida | — | — |
| Site 952 | Tallahassee | Florida | — | — |
| Site 931 | Tampa | Florida | — | — |
| Site 908 | Decatur | Georgia | — | — |
| Site 905 | Boise | Idaho | — | — |
| Site 914 | Chicago | Illinois | — | — |
| Site 928 | Louisville | Kentucky | — | — |
| Site 955 | Louisville | Kentucky | — | — |
| Site 958 | New Orleans | Louisiana | — | — |
| Site 934 | Boston | Massachusetts | — | — |
| Site 915 | Springfield | Missouri | — | — |
| Site 956 | Somers Point | New Jersey | — | — |
| Site 921 | Albany | New York | — | — |
| Site 910 | Cincinnati | Ohio | — | — |
| Site 941 | Philadelphia | Pennsylvania | — | — |
| Site 925 | Dallas | Texas | — | — |
| Site 917 | Fort Worth | Texas | — | — |
| Site 906 | Houston | Texas | — | — |
| Site 942 | Houston | Texas | — | — |
| Site 909 | Tacoma | Washington | — | — |
| Site 927 | Vancouver | Washington | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00642499, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 1, 2008 · Synced Apr 29, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00642499 live on ClinicalTrials.gov.